Nutrition, exercise and olanzapine for appetite in advanced cancer
Part of Cancer, Hormones & metabolism clinical trials.
This trial tests if adding a nutrition and exercise program to the medication olanzapine can help improve appetite and quality of life in people with advanced solid tumors. Olanzapine is already sometimes used to boost appetite; this study wants to see if extra support makes it work better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You have a solid tumor that has spread or can't be cured (not lymphoma).
- You have poor appetite (a score of 70 or less out of 100).
- You are able to do some physical activity, as approved by your doctor.
- You are not currently taking antipsychotic or antidepressant medication.
- You are not on tube feeding or IV nutrition (except certain oral supplements).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the drug olanzapine can help improve appetite and reduce weight loss in people with advanced cancer who are not currently receiving chemotherapy or other anti-cancer treatment. It may be an option if you have lost weight and have little appetite.
This Phase 2 trial tests whether olanzapine can help people with advanced cancer who are losing weight and not eating enough. It looks for improvements in appetite and weight while you receive your first-line palliative cancer treatment.
This study tests whether olanzapine, a medication that can increase appetite, helps prevent severe appetite loss and muscle wasting in patients with ovarian or stomach cancer who are receiving chemotherapy before surgery. The goal is to help patients maintain nutrition and strength during treatment.
This trial tests if the drug olanzapine can help improve appetite in people with head and neck cancer who are getting chemotherapy and radiation. It aims to prevent or reduce weight loss during treatment.
This study tests whether a medicine called olanzapine can improve survival in people with advanced cancers of the upper digestive system or lungs. Olanzapine may help with appetite and weight, which are common problems in these cancers.
This trial tests whether adding nutrition support helps cancer patients with malnutrition respond better to immunotherapy. You may be able to join if you have cancer and are malnourished, are generally active, and can swallow pills.
Hear when a new Malnutrition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.